Advances in silica based nanoparticles for targeted cancer therapy.

[1]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[2]  Xing-jie Liang,et al.  Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite. , 2015, ACS nano.

[3]  Jie Zheng,et al.  Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.

[4]  Jishan Li,et al.  Targeted Intracellular Controlled Drug Delivery and Tumor Therapy through in Situ Forming Ag Nanogates on Mesoporous Silica Nanocontainers. , 2015, ACS applied materials & interfaces.

[5]  Hao Hong,et al.  Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. , 2015, Nanomedicine.

[6]  Hao Hong,et al.  In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine , 2015, ACS nano.

[7]  Qinfu Zhao,et al.  Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. , 2015, ACS applied materials & interfaces.

[8]  Younan Xia,et al.  Engineered Nanoparticles for Drug Delivery in Cancer Therapy * , 2015, Nanomaterials and Neoplasms.

[9]  M. Vallet‐Regí,et al.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery , 2015, Expert opinion on drug delivery.

[10]  Qiang Zhang,et al.  The development of site-specific drug delivery nanocarriers based on receptor mediation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Hao Hong,et al.  VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System , 2014, ACS applied materials & interfaces.

[12]  Qianjun He,et al.  MSN‐Mediated Sequential Vascular‐to‐Cell Nuclear‐Targeted Drug Delivery for Efficient Tumor Regression , 2014, Advanced materials.

[13]  Qingfeng Xiao,et al.  A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging. , 2014, Biomaterials.

[14]  M. Maynadier,et al.  Biodegradable Ethylene‐Bis(Propyl)Disulfide‐Based Periodic Mesoporous Organosilica Nanorods and Nanospheres for Efficient In‐Vitro Drug Delivery , 2014, Advanced materials.

[15]  Hui-Xiong Xu,et al.  A combined "RAFT" and "Graft From" polymerization strategy for surface modification of mesoporous silica nanoparticles: towards enhanced tumor accumulation and cancer therapy efficacy. , 2014, Journal of materials chemistry. B.

[16]  D. Kim,et al.  Enhanced tumor targetability of PEGylated mesoporous silica nanoparticles on in vivo optical imaging according to their size , 2014 .

[17]  Hao Hong,et al.  In Vivo Tumor Vasculature Targeted PET/NIRF Imaging with TRC105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles , 2014, Molecular pharmaceutics.

[18]  D. Zhao,et al.  Facile Synthesis of Yolk–Shell Structured Inorganic–Organic Hybrid Spheres with Ordered Radial Mesochannels , 2014, Advanced materials.

[19]  Zhenhua Li,et al.  A Smart Nanoassembly for Multistage Targeted Drug Delivery and Magnetic Resonance Imaging , 2014 .

[20]  Feng Chen,et al.  Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy , 2014, Scientific Reports.

[21]  Chuanglong He,et al.  Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. , 2014, ACS applied materials & interfaces.

[22]  Jiaqiang Xu,et al.  A robust graft-to strategy to form multifunctional and stealth zwitterionic polymer-coated mesoporous silica nanoparticles. , 2014, Biomacromolecules.

[23]  Wolfgang J. Parak,et al.  Protein corona formation around nanoparticles – from the past to the future , 2014 .

[24]  Bolin Liu,et al.  Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent. , 2014, Colloids and surfaces. B, Biointerfaces.

[25]  Jun-Jie Zhu,et al.  DNA-hybrid-gated multifunctional mesoporous silica nanocarriers for dual-targeted and microRNA-responsive controlled drug delivery. , 2014, Angewandte Chemie.

[26]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[27]  Chengzhong Yu,et al.  Rod-like mesoporous silica nanoparticles with rough surfaces for enhanced cellular delivery. , 2014, Journal of materials chemistry. B.

[28]  Hongwei Zhang,et al.  Facile synthesis of ultra-small hybrid silica spheres for enhanced penetration in 3D glioma spheroids. , 2014, Chemical communications.

[29]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[30]  J. Zou,et al.  Nanoparticles Mimicking Viral Surface Topography for Enhanced Cellular Delivery , 2013, Advanced materials.

[31]  Hao Hong,et al.  In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. , 2013, ACS nano.

[32]  Zipeng Zhen,et al.  Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery , 2013, Theranostics.

[33]  Yongsheng Li,et al.  Colloidal HPMO Nanoparticles: Silica‐Etching Chemistry Tailoring, Topological Transformation, and Nano‐Biomedical Applications , 2013, Advanced materials.

[34]  陈雨,et al.  In Vivo Bio-Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles , 2013 .

[35]  Hong Yang,et al.  VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro , 2013, International journal of nanomedicine.

[36]  Si-Han Wu,et al.  Synthesis of mesoporous silica nanoparticles. , 2013, Chemical Society reviews.

[37]  Kai Yang,et al.  Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. , 2013, Biomaterials.

[38]  Phapanin Charoenphol,et al.  Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[39]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[40]  王立军,et al.  Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles , 2013 .

[41]  Chengzhong Yu,et al.  Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. , 2013, Nanoscale.

[42]  Kinam Park,et al.  Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Jun Wang,et al.  Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor , 2012, Advanced materials.

[44]  Le-Le Li,et al.  Polyvalent Mesoporous Silica Nanoparticle‐Aptamer Bioconjugates Target Breast Cancer Cells , 2012, Advanced healthcare materials.

[45]  Mary E Napier,et al.  The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[46]  S. A. Dergunov,et al.  Permission to enter cell by shape: nanodisk vs nanosphere. , 2012, ACS applied materials & interfaces.

[47]  K. Landfester,et al.  How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. , 2012, Small.

[48]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[49]  Donald E Ingber,et al.  Microengineered physiological biomimicry: organs-on-chips. , 2012, Lab on a chip.

[50]  Yin Zhang,et al.  Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. , 2012, Biomaterials.

[51]  Kai Yang,et al.  In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. , 2012, ACS nano.

[52]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[53]  Yu Chen,et al.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.

[54]  Zongxi Li,et al.  Mesoporous silica nanoparticles in biomedical applications. , 2012, Chemical Society reviews.

[55]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[56]  Dong Chen,et al.  Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. , 2012, Biomaterials.

[57]  J. Zink,et al.  In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[58]  Fan Zhang,et al.  Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. , 2012, Nano letters.

[59]  D. Ingber,et al.  From 3D cell culture to organs-on-chips. , 2011, Trends in cell biology.

[60]  J. Fei,et al.  Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation. , 2011, Chemistry.

[61]  Lauren A Austin,et al.  Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. , 2011, Bioconjugate chemistry.

[62]  Lauren A Austin,et al.  Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles. , 2011, Journal of the American Chemical Society.

[63]  Ou Chen,et al.  Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. , 2011, Angewandte Chemie.

[64]  F. Gu,et al.  Surface functionalization of silica nanoparticles with cysteine: a low-fouling zwitterionic surface. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[65]  Courtney R. Thomas,et al.  Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. , 2011, Small.

[66]  P. Chu,et al.  Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. , 2011, Biomaterials.

[67]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[68]  Soumen Das,et al.  PEGylated Inorganic Nanoparticles , 2011 .

[69]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[70]  Mark B. Carter,et al.  Erratum: The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers (Nature Materials (2011) 10 (389-397)) , 2011 .

[71]  Zongxi Li,et al.  Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. , 2011, ACS nano.

[72]  S. Arai,et al.  Aqueous colloidal mesoporous nanoparticles with ethenylene-bridged silsesquioxane frameworks. , 2011, Journal of the American Chemical Society.

[73]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[74]  Leone Spiccia,et al.  Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.

[75]  L. Spiccia,et al.  Cancer Research: Nanomaterials: Applications in Cancer Imaging and Therapy (Adv. Mater. 12/2011) , 2011 .

[76]  Hideyoshi Harashima,et al.  A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. , 2011, Advanced drug delivery reviews.

[77]  Kazuo Maruyama,et al.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.

[78]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[79]  Yu Chen,et al.  Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands , 2011 .

[80]  P. Liu,et al.  Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. , 2011, Angewandte Chemie.

[81]  Yaping Li,et al.  In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.

[82]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[83]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[84]  S. Nie,et al.  A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.

[85]  Cecilia Sahlgren,et al.  Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.

[86]  T. Bein,et al.  Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles , 2010 .

[87]  Jong Hwan Sung,et al.  Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling , 2010, Expert opinion on drug metabolism & toxicology.

[88]  Zongxi Li,et al.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.

[89]  Jeremy L. Steinbacher,et al.  Enhanced uptake of porous silica microparticles by bifunctional surface modification with a targeting antibody and a biocompatible polymer. , 2010, ACS applied materials & interfaces.

[90]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[91]  Xinglu Huang,et al.  The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. , 2010, Biomaterials.

[92]  Kai Yang,et al.  Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.

[93]  J. Ho,et al.  Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding. , 2010, ACS nano.

[94]  T. Bein,et al.  Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol) , 2010 .

[95]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[96]  J. Eriksson,et al.  Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. , 2010, Small.

[97]  Nai-Tzu Chen,et al.  The protease-mediated nucleus shuttles of subnanometer gold quantum dots for real-time monitoring of apoptotic cell death. , 2010, Journal of the American Chemical Society.

[98]  J. Fei,et al.  Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers. , 2010, Physical chemistry chemical physics : PCCP.

[99]  Christy L Haynes,et al.  Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. , 2010, Journal of the American Chemical Society.

[100]  Indrajit Roy,et al.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.

[101]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[102]  Jeffrey I. Zink,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery , 2010, BiOS.

[103]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[104]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[105]  Weihong Tan,et al.  DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells , 2009, Proceedings of the National Academy of Sciences.

[106]  Sei-Young Lee,et al.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.

[107]  Huang-Hao Yang,et al.  An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates , 2009 .

[108]  Y. Hung,et al.  Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells , 2009 .

[109]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[110]  J. Irache,et al.  Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[111]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[112]  Jong Hwan Sung,et al.  A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. , 2009, Lab on a chip.

[113]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[114]  Xiaoling Zhang,et al.  Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells , 2009, Chembiochem : a European journal of chemical biology.

[115]  Juewen Liu,et al.  Functional nucleic acid sensors. , 2009, Chemical reviews.

[116]  Shaoyi Jiang,et al.  Novel zwitterionic-polymer-coated silica nanoparticles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[117]  C. Jeffrey Brinker,et al.  Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. , 2009, Journal of the American Chemical Society.

[118]  Rasmus Niemi,et al.  Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.

[119]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[120]  Esther H Chang,et al.  Does a targeting ligand influence nanoparticle tumor localization or uptake? , 2008, Trends in biotechnology.

[121]  Jianlin Shi,et al.  Uniform Rattle‐type Hollow Magnetic Mesoporous Spheres as Drug Delivery Carriers and their Sustained‐Release Property , 2008 .

[122]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[123]  Cheuk Y. Tang,et al.  Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. , 2008, Nano letters.

[124]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[125]  Brian G. Trewyn,et al.  Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration , 2008 .

[126]  Chenjie Xu,et al.  Monodisperse magnetite nanoparticles coupled with nuclear localization signal peptide for cell-nucleus targeting. , 2008, Chemistry, an Asian journal.

[127]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[128]  Omid C Farokhzad,et al.  Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates , 2007, ChemMedChem.

[129]  Alexander T Florence,et al.  Pharmaceutical nanotechnology: more than size. Ten topics for research. , 2007, International journal of pharmaceutics.

[130]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[131]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[132]  Robert Langer,et al.  An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. , 2006, Angewandte Chemie.

[133]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[134]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[135]  Yong Wang,et al.  Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras , 2006, Nature Biotechnology.

[136]  E. Hoek,et al.  Extended DLVO interactions between spherical particles and rough surfaces. , 2006, Journal of colloid and interface science.

[137]  T. Ishida,et al.  Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[138]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[140]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[141]  Shaoyi Jiang,et al.  Strong resistance of oligo(phosphorylcholine) self-assembled monolayers to protein adsorption. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[142]  I. Tannock,et al.  The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.

[143]  J. Kos,et al.  Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours , 2005, Expert opinion on biological therapy.

[144]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[145]  Shaoyi Jiang,et al.  Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials. , 2005, Journal of the American Chemical Society.

[146]  F. Ducongé,et al.  Aptamers against extracellular targets for in vivo applications. , 2005, Biochimie.

[147]  Jesus M de la Fuente,et al.  Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.

[148]  Xin Yu Wang,et al.  Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[149]  Huajian Gao,et al.  Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Roy Bicknell,et al.  Tumour vascular targeting , 2005, Nature Reviews Cancer.

[151]  T. Allen,et al.  Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. , 2005, Biochimica et biophysica acta.

[152]  T. Ishida,et al.  Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[153]  Y. Hiraku,et al.  Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. , 2005, Life sciences.

[154]  Omid C. Farokhzad,et al.  Nanoparticle-Aptamer Bioconjugates , 2004, Cancer Research.

[155]  D. P. O'Neal,et al.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.

[156]  Daniele Gerion,et al.  Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and , 2004 .

[157]  Shinsuke Sando,et al.  A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.

[158]  Tae Gwan Park,et al.  Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[159]  R. Netz,et al.  Electrostatic colloid-membrane complexation , 2003, physics/0312121.

[160]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[161]  T. Ishida,et al.  Accelerated clearance of a second injection of PEGylated liposomes in mice. , 2003, International journal of pharmaceutics.

[162]  S. Franzen,et al.  Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. , 2003, Journal of the American Chemical Society.

[163]  Kazunori Kataoka,et al.  PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .

[164]  T. Ishida,et al.  Accelerated clearance of PEGylated liposomes in rats after repeated injections. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[165]  Buddy D. Ratner,et al.  PEO-like plasma polymerized tetraglyme surface interactions with leukocytes and proteins: in vitro and in vivo studies , 2002, Journal of biomaterials science. Polymer edition.

[166]  W. Oyen,et al.  Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.

[167]  G. Whitesides,et al.  A Survey of Structure−Property Relationships of Surfaces that Resist the Adsorption of Protein , 2001 .

[168]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[169]  Milan Mrksich,et al.  Self-assembled monolayers of alkanethiolates presenting mannitol groups are inert to protein adsorption and cell attachment , 2000 .

[170]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[171]  W. Oyen,et al.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.

[172]  S. Kagatani,et al.  In vivo fate of folate-BSA in non-tumor- and tumor-bearing mice. , 1998, Journal of pharmaceutical sciences.

[173]  F. Burrows,et al.  Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[174]  H. Maeda,et al.  Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. , 1992, Bioconjugate chemistry.

[175]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[176]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[177]  Jacques Barbet,et al.  Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A , 1980, Nature.

[178]  S. Goff,et al.  Construction of hybrid viruses containing SV40 and λ phage DNA segments and their propagation in cultured monkey cells , 1976, Cell.

[179]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[180]  W. Woglom.  A Critique of Tumor Resistance , 1922 .

[181]  Yaping Li,et al.  Gene Delivery: Large-Pore Ultrasmall Mesoporous Organosilica Nanoparticles: Micelle/Precursor Co-templating Assembly and Nuclear-Targeted Gene Delivery (Adv. Mater. 2/2015) , 2015 .

[182]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[183]  B. Seon,et al.  Endoglin-targeted cancer therapy. , 2011, Current drug delivery.

[184]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[185]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[186]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[187]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. , 2009, Small.

[188]  Si-Shen Feng,et al.  Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. , 2006, Biomaterials.

[189]  T. Ishida,et al.  The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study. , 2002, Cellular & molecular biology letters.

[190]  O. Boerman,et al.  In vivo applications of PEG liposomes: unexpected observations. , 2001, Critical reviews in therapeutic drug carrier systems.

[191]  D. Leckband,et al.  Grafted poly(ethylene oxide) brushes as nonfouling surface coatings. , 1999, Journal of biomaterials science. Polymer edition.